1. de Smet M, Dayan M. Prospective determination of T cell responses to S-antigen in Behçet’s disease patients and controls. Invest Ophthalmol Vis Sci. 2000; 41:3480–4.
2. Brewerton DA, Caffrey M, Nicholls A. . Acute anterior uveitis and HL-A 27. Lancet. 1973; 2:994–6.
Article
3. Ali A, Samson M. Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol. 2007; 18:476–80.
Article
4. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998; 105:1646–51.
Article
5. Otasevic L, Zlatanovic G, Stanojevic-Paovic A. . Helicobacter pylori: an underestimated factor in acute anterior uveitis and spondyloarthropathy? Ophthalmologica. 2007; 221:6–13.
6. Reveille JD, Arnett FC. Spondyloarthritis: update on pathogenesis and management. Am J Med. 2005; 118:592–603.
Article
7. Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005; 17:400–5.
Article
8. Magone MT, Whitcup SM. Mechanisms of intraocular inflammation. Chem Immunol. 1999; 73:90–119.
Article
9. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12:121–7.
10. Bonecchi R, Bianchi G, Bordignon PP. . Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187:129–34.
Article
11. Sallusto F, Lenig D, MacKay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998; 187:875–83.
Article
12. Klok AM, Luyendijk L, Zaal MJ. . Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol. 1998; 82:871–4.
Article
13. Bloch-Michel E, Nussenblatt R. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987; 103:234–5.
Article
14. Rossi D, Zlotinik A. The biology of chemokines and their receptors. Ann Rev Immunol. 2000; 18:217–42.
Article
15. Howard O, Dong H, Su S. . Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood. 2005; 105:4207–14.
Article
16. Wallace GR, Curnow SJ, Wloka K. . The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res. 2004; 23:435–48.
Article
17. Fang IM, Yang CH, Lin CP. . Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res. 2004; 78:1043–55.
Article
18. Kaburaki T, Fujino Y, Kawashima H. . Plasma and whole-blood chemokine levels in patients with Behcet’s disease. Graefes Arch Clin Exp Ophthalmol. 2003; 241:353–8.
Article
19. Abu El-Asrar AM, Struyf S, Descamps FJ. . Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol. 2004; 138:401–11.
Article
20. Imai Y, Ohno S. Helper T-cell subsets in uveitis. Int Ophthalmol Clin. 2002; 42:25–32.
Article
21. Frassanito MA, Dammacco R, Fusaro T. . Combined cyclosporine-A/prednisone therapy of patients with active uveitis suppresses IFN-γ production and the function of dendritic cell. Clin Exp Immunol. 2003; 133:233–9.
22. Yang CH, Fang IM, Lin CP. . Effects of the NF-kappa B inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2005; 46:1339–47.
23. Crane IJ, Mckillop-Smith S, Wallace CA. . Expression of the chemokines MIP-1α, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001; 42:1547–52.
24. Ohta K, Yamagami S, Wiggert B. . Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis. Curr Eye Res. 2002; 24:451–7.
Article
25. Keino H, Takeuchi M, Kezuka T. . Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch Clin Exp Ophthalmol. 2003; 241:111–5.
Article
26. Onal S, Kazokoglu H, Incili B. Prevalence and levels of serum antibodies to gram negative microorganisms in Turkish patients with HLA-B27 positive acute anterior uveitis and controls. Ocul Immunol Inflamm. 2006; 14:29309.
Article
27. Gür-Toy G, Lenk N, Yalcin B. . Serum interleukin-8 as a serologic marker of activity in Behcet's disease. Int J Dermatol. 2005; 44:657–60.
Article
28. Murphy P. The molecular biology of leukocyte chemoattractant receptors, Annu Rev Immunol. 1994; 12:593–633.
29. Sauty A, Colvin R, Wagner L. . CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J Immunol. 2001; 167:7084–93.
30. Hess C, Means T, Autissier P. . IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood. 2004; 104:3463–71.
Article
31. Hattar K, Fink L, Fietzner K. . Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors. J Immunol. 2001; 166:6287–93.
Article
32. Yu HG, Lee DS, Seo JM. . The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet’s uveitis. Clin Exp Immunol. 2004; 137:437–43.
Article
33. Ahn JK, Chung H, Lee DS. . CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behçet's uveitis. J Immunol. 2005; 175:6133–42.